Your browser doesn't support javascript.
loading
Sudden blast phase in chronic myeloid leukemia developed during nilotinib therapy after major molecular response was achieved.
Okada, Yosuke; Sato, Ken; Kobayashi, Shinichi; Nagao, Shigeki; Takano, Kosuke; Teramoto, Masahiro; Tachi, Noriaki; Kawamura, Toshikuni; Horiuchi, Toshikatsu; Kato, Shoichiro; Saga, Reina; Maekawa, Takaaki; Yamamura, Takeshi; Watanabe, Junichi; Kobayashi, Ayako; Kimura, Fumihiko.
Afiliación
  • Okada Y; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan. fukurora_mochi@yahoo.co.jp.
  • Sato K; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Kobayashi S; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Nagao S; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Takano K; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Teramoto M; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Tachi N; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Kawamura T; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Horiuchi T; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Kato S; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Saga R; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Maekawa T; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Yamamura T; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Watanabe J; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Kobayashi A; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
  • Kimura F; Division of Hematology, Department of Internal Medicine, National Defense Medical College Hospital, 3-2 Namiki, Tokorozawa, Saitama, 359-0042, Japan.
Int J Hematol ; 107(4): 495-497, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29032513
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Crisis Blástica / Inhibidores Enzimáticos / Sustitución de Medicamentos Tipo de estudio: Screening_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Crisis Blástica / Inhibidores Enzimáticos / Sustitución de Medicamentos Tipo de estudio: Screening_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón